Summary
Using the reverse transcription-polymerase chain reaction (RT-PCR), we developed a sensitive and quantitative method to detect all four types of human tyrosine hydroxylase (TH) mRNAs in the human brain (substantia nigra). All four types of TH mRNAs were found in the substantia nigra in the control brains examined, and the ratio of type-1, type-2, type-3, and type-4 mRNAs to the total amount of TH was 45, 52, 1.4, and 2.1%, respectively. The average amount of total TH mRNA in the normal brain (substantia nigra) was 5.5 amol of TH mRNA per μg of total RNA. The ratios of four TH isoforms were not altered significantly in Parkinson's disease or schizophrenia. Further we measured the relative amount of aromatic L-amino acid decarboxylase (AADC) and β-actin mRNAs in the brain samples. TH and AADC mRNAs were highly correlated in the control cases. We found that parkinsonian brains had very low levels of all four TH isoforms and AADC mRNAs in the substantia nigra compared with control brains, while no significant differences were found between schizophrenic brains and normal ones. Since the decrease in AADC mRNA was comparable to that in TH mRNA, the alteration of TH in Parkinson's disease would not be a primary event, but it would reflect the degeneration of dopaminergic neurons in the substantia nigra. This is the first reported measurement of mRNA contents of TH isoforms and AADC in Parkinson's disease and schizophrenia.
This is a preview of subscription content, log in via an institution to check access.
References
Coker I GT, Studelska D, Harmon S, Burke W, O'Malley KL (1990) Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Mol Brain Res 8: 93–98
Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antishizophrenic drugs. Science 192: 481–483
Crow TJ, Baker HF, Cross AJ, Joseph MH, Lofthouse R, Longden A, Owen F, Riley GJ, Glover V, Killpack WS (1979) Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings. Br J Psychiatry 134: 249–256
Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148: 1474–1486
Grima B, Lamouroux A, Boni C, Julien J-F, Javoy-Agid F, Mallet J (1987) A single human gene encoding multiple tyrosine hydroxylase with different predicted functional characteristics. Nature 326: 707–711
Haycock JW (1993) Multiple forms of tyrosine hydroxylase in human neuroblastoma cells: quantitation with isoform-specific antibodies. J Neurochem 60: 493–502
Ichinose H, Kurosawa Y, Titani K, Fujita K, Nagatsu T (1989) Isolation and characterization of a cDNA clone encoding human aromatic L-amino acid decarboxylase. Biochem Biophys Res Commun 164: 1024–1030
Ichinose H, Ohye T, Fujita K, Yoshida M, Ueda S, Nagatsu T (1993) Increased heterogeneity of tyrosine hydroxylase in humans. Biochem Biophys Res Commun 195: 158–165
Kaneda N, Kobayashi K, Ichinose H, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T (1987) Isolation of a novel cDNA clone for human tyrosine hydroxylase: alternative RNA splicing produces four kinds of mRNA from a single gene. Biochem Biophys Res Commun 146: 971–975
Kastner A, Hirsch EC, Agid Y, Javoy-Agid F (1993) Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease. Brain Res 606: 341–345
Kilbourne EJ, Nankova BB, Lewis EJ, McMahon A, Osaka H, Sabban DB, sabban EL (1992) Regulated expression of the tyrosine hydroxylase gene by membrane depolarization: identification of the responsive element and possible second messengers. J Biol Chem 267: 7563–7569
Kobayashi K, Kaneda N, Ichinose H, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T (1988) Structure of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA types. J Biochem 103: 907–912
Levitt M, Spector S, Sjoerdsma A, Udenfriend S (1965) Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J Pharmacol Exp Ther 148: 1–8
Lewis DA, Melchitzky DS, Haycock JW (1993) Four isoforms of tyrosine hydroxylase are expressed in human brain. Neuroscience 54: 477–492
Lovenberg W, Weissbach H, Uenfriend S (1962) Aromatic L-amino acid decarboxylase. J Biol Chem 237: 89–93
Nagatsu T, Ichinose H (1991) Comparative studies on the structure of human tyrosine hydroxylase with those of the enzyme of various mammals. Comp Biochem Physiol 98C: 203–210
Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase: the initial step in norepinephrine biosynthesis. J Biol Chem 239: 2910–2917
Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T (1985) Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82: 6133–6137
O'Malley KL, Anhalt MJ, Martin BM, Kelsoe JR, Winfield SL, Ginns EI (1987) Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5′ alternative splice sites responsible for multiple mRNAs. Biochemistry 26: 6910–6914
Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261: 717–719
Toru M, Nishikawa T, Mataga N, Takashima M (1982) Dopamine metabolism increases in post-mortem schizophrenic basal ganglia. J Neural Transm 54: 181–191
Wang MA, Doyle MV, Mark DF (1989) Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86: 9717–9721
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ichinose, H., Ohye, T., Fujita, K. et al. Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophrenia. J Neural Transm Gen Sect 8, 149–158 (1994). https://doi.org/10.1007/BF02250926
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02250926